Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1033678 | 0.81 | FFAR3 (0.41) | ALDH1A1TSHR | |
| Ethyl Acetate SCHEMBL3986904 | 0.78 | ALDH1A1 (0.58) | ALDH1A1TSHRHSD17B10GAA | |
| Oxalic Acid SCHEMBL27763558 | 0.76 | CYP1A2 (0.37) | ALDH1A1TSHR | |
| Sulfuric Acid SCHEMBL28150852 | 0.76 | CA5A (0.35) | TSHRCYP2C19 | |
| Sulfuric Acid SCHEMBL16910003 | 0.76 | CA5A (0.35) | TSHRCYP2C19 | |
| Bicarbonate SCHEMBL28262249 | 0.76 | CYP1A2 (0.37) | ALDH1A1TSHR | |
| Methyl Alcohol SCHEMBL27508368 | 0.74 | ALDH1A1 (0.35) | ALDH1A1CYP2C19 | |
| SCHEMBL1980 | 0.74 | — | — | |
| Pivalate SCHEMBL1831112 | 0.74 | CYP2D6 (0.40) | ALDH1A1TSHRCYP2C19 | |
| Ammonia Solution, Strong SCHEMBL4950713 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171628-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COVID-19 AND RELATED PATHOLOGIES | Unthreadt B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| WO-2021261993-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COVID-19 AND RELATED PATHOLOGIES | UNTHREADT B.V. (NL) | 2021-12-30 | — | — | WO | disclosed |
| CN-101443080-B | Use of peptides for controlling radiation damage | BIOTEMPT BV | 2015-01-14 | — | — | CN | disclosed |
| US-8680059-B2 | Oligopeptide acetate and formulations thereof | BIOTEMPT B.V. (NL) | 2014-03-25 | — | — | US | disclosed |
| EP-1996292-B1 | USE OF PEPTIDES FOR THE CONTROL OF RADIATION INJURY | BIOTEMPT BV (NL) | 2012-10-31 | — | — | EP | disclosed |
| US-8288341-B2 | Control of radiation injury | BIOTEMPT B.V. (NL) | 2012-10-16 | — | — | US | disclosed |
| US-8216998-B2 | Use of human chorionic gonadotropin (hCG)-derived peptides; reperfusion injuries; NF-kappa B-down-regulating peptide | BIOTEMPT B.V. (NL) | 2012-07-10 | — | — | US | disclosed |
| WO-2012024668-A3 | DOSAGE DISPENSING CAP SYSTEM | AMIN JOSEPH (US) | 2012-05-10 | — | — | WO | disclosed |
| US-RE43309-E1 | Immunoregulatory compositions | BIOTEMPT B.V. (NL) | 2012-04-10 | — | — | US | disclosed |
| EP-1615655-B1 | USE OF COMPOSITIONS FOR MUCOSAL AND ORAL ADMINISTRATION COMPRISING HCG FRAGMENTS | BIOTEMPT BV (NL) | 2012-02-22 | — | — | EP | disclosed |
| US-20030113733-A1 | Transcription factors; nuclear localization peptides; human chorionic gonadotropic hormone(hCG); NF-kappaB/Rel proteins | BIOTEMPT B.V. (NL) | 2003-06-19 | — | — | US | disclosed |
| WO-2003029292-A2 | GENE REGULATORY PEPTIDES | ERASMUS UNIVERSITEIT ROTTERDAM (NL) | 2003-04-10 | — | — | WO | disclosed |
| EP-1300418-A1 | Gene regulation by oligopeptides | Erasmus Universiteit Rotterdam (NL) | 2003-04-09 | — | — | EP | disclosed |
| EP-1272515-A2 | IMMUNOREGULATOR | Erasmus Universiteit Rotterdam (NL) | 2003-01-08 | — | — | EP | disclosed |
| WO-2001072831-A2 | IMMUNOREGULATOR | ERASMUS UNIVERSITEIT ROTTERDAM (NL) | 2001-10-04 | — | — | WO | disclosed |
| EP-0804252-A2 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATECH, INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1995033497-A1 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATECH, INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| EP-0505385-A4 | ANTI-AGGREGATORY PEPTIDES CONTAINING A MERCAPTAN OR SULFIDE MOIETY | — | 1993-05-05 | — | — | EP | disclosed |
| EP-0505385-A1 | ANTI-AGGREGATORY PEPTIDES CONTAINING A MERCAPTAN OR SULFIDE MOIETY | SMITHKLINE BEECHAM CORPORATION (US) | 1992-09-30 | — | — | EP | disclosed |
| WO-1991007429-A1 | ANTI-AGGREGATORY PEPTIDES CONTAINING A MERCAPTAN OR SULFIDE MOIETY | SMITHKLINE BEECHAM CORPORATION (US) | 1991-05-30 | — | — | WO | disclosed |